Published on 18 November 2013
RAM Ratings has reaffirmed the
enhanced ratings of Aspion Sdn Bhd’s (Aspion or the Group) RM150 million
Islamic Commercial Papers/Islamic Medium-Term Notes Programme (2012/2018) (the
Sukuk) at AAA(bg)/Stable/P1(bg). The enhanced ratings reflect the unconditional
and irrevocable guarantee extended by Maybank Islamic Berhad (rated
AAA/Stable/P1), which enhances the credit profile of the Sukuk beyond Aspion’s
stand-alone credit strength. The Group primarily manufactures and distributes
surgical, dental and examination gloves.
Aspion’s stand-alone credit
profile is underpinned by its position as a reputable surgical-glove producer.
Relative to examination gloves which are more commoditised, the specialised
application of surgical gloves heightens the entry barriers of this segment as
more stringent regulations apply. Demand for medical gloves is viewed as
resilient, supported by their essential function as a protective barrier within
the healthcare sector. The Group’s satisfactory financial profile also
continues to support its credit standing.
Aspion’s top line inched up and
its profitability improved amid softer natural latex prices in FY Oct 2012. Its
operating profit before depreciation, interest & tax (OPBDIT) margin
increased to 10.80% from 7.94% for FY Oct 2011. Natural latex prices continued
to soften in the first 7 months of FY Oct 2013, contributing to a higher OPBDIT
margin of 13.20%. The Group’s cashflow protection metrics had also improved.
Aspion’s funds from operations debt coverage (FFODC) ratio was 0.26 times in 7M
FY Oct 2013, up from 0.19 times in FY Oct 2011, given its better profit
performance amid lower raw material prices. The Group’s increased debt load was
cushioned by its enlarged equity, resulting in a gearing ratio of 0.87 times as
at end-May 2013, unchanged from end-FY Oct 2011.
“Aspion’s gearing ratio is
expected to hover around 1–1.2 times as the Group seeks to fund its near-term
growth plans through debt and internally-generated cashflow,” notes Kevin Lim,
RAM’s Head of Consumer and Industrial Ratings. “Meanwhile, contributions from
its expanded operations are envisaged to support the Group’s FFODC ratio at
around 0.2 times,” adds Lim.
We view Aspion’s planned RM170
million capacity expansion to build a new surgical-glove plant in Kulim as
aggressive. The expansion is forecasted to more than triple the Group’s
surgical gloves capacity to approximately 2.5 billion pieces by end-FY Oct 2017.
We view the projected increased production as optimistic, as Aspion may
experience challenges in strengthening the Group’s distribution network to tap
into new markets and increase its market share.
We note that Southern Capital
Group (Southern Capital), Aspion’s controlling shareholder, is a private equity
sponsor. Typically, private equity investors have a shorter investment time
frame and can initiate major changes at the companies they acquire. Hence, we
do not discount the possibility of further expansion plans or additional
leveraging, which may exert greater strain on the Group’s financial profile.
Aspion’s financial profile may also be pressured if its receivables profile
continues to worsen if the southern European economies, where many of its
aged-receivables clients are located, remain mired in recession.
Elsewhere, Aspion’s credit
profile is moderated by its vulnerability to fluctuating input prices and
volatile forex movements. Aggressive expansion of production capacity by Aspion
and its peers is expected to intensify competition within the
already-competitive glove market, thereby increasing pressure on the Group’s
profitability.
Media contact
Carol Pang
603 7628 1076
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.